申请人:Glycomed Incorporated
公开号:US05874411A1
公开(公告)日:1999-02-23
Disclosed are novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties, pharmaceutical compositions containing such oligosaccharide glycosides and to methods of using such oligosaccharide glycosides to modulate cell-mediated immune responses in a mammal.
揭示了具有哺乳动物免疫抑制和耐受性特性的新型寡糖糖苷,包含这种寡糖糖苷的药物组合物以及使用这种寡糖糖苷调节哺乳动物细胞介导免疫应答的方法。